Literature DB >> 21187187

Hyperinsulinemia and the development of nonalcoholic Fatty liver disease in nondiabetic adults.

Eun-Jung Rhee1, Won-Young Lee, Yong-Kyun Cho, Byung-Ik Kim, Ki-Chul Sung.   

Abstract

BACKGROUND: insulin resistance is known to be the most important pathogenic factor in the development of nonalcoholic fatty liver disease. We performed a prospective study to analyze the associations of baseline and changes in fasting insulin levels with future development of nonalcoholic fatty liver disease in nondiabetic adults over a 5-year period.
METHODS: this study was performed in 4954 subjects who did not have diabetes or nonalcoholic fatty liver disease and who participated in a health checkup program in both 2003 and 2008. The presence of nonalcoholic fatty liver disease was defined by ultrasonographic examination. Subjects were divided into 4 groups according to the baseline quartiles of fasting insulin and dichotomized fasting insulin levels at baseline and after 5 years: low-low, low-high, high-low, high-high.
RESULTS: after 5 years, 644 subjects (13%) developed nonalcoholic fatty liver disease. The odds ratio (OR) for development of nonalcoholic fatty liver disease increased as the quartiles of the baseline fasting insulin levels increased from the first to the fourth quartile (1.00 vs. 0.99, 1.44, 1.65, respectively). The OR for nonalcoholic fatty liver disease was 2.5-fold higher in the high-high group and 1.6-fold higher in the low-high group compared with that of the low-low group. The OR for nonalcoholic fatty liver disease increased as the quartile of changes in fasting insulin level over the 5-year period increased.
CONCLUSION: high baseline and continuously increasing fasting insulin levels were the independent determinants for future development of nonalcoholic fatty liver disease during a 5-year follow-up in nondiabetic healthy adults. 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21187187     DOI: 10.1016/j.amjmed.2010.08.012

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  17 in total

1.  Sonographic Features of the Liver Among Females with Type 2 Diabetes.

Authors:  Bárbara L Riestra-Candelaria; Loida A González-Rodríguez; Wilma Rodriguez-Mojica; Luis E Vázquez-Quiñones; Juan Carlos Jorge
Journal:  J Diagn Med Sonogr       Date:  2019-03-08

2.  Prevention of hepatocellular adenoma and correction of metabolic abnormalities in murine glycogen storage disease type Ia by gene therapy.

Authors:  Young Mok Lee; Hyun Sik Jun; Chi-Jiunn Pan; Su Ru Lin; Lane H Wilson; Brian C Mansfield; Janice Y Chou
Journal:  Hepatology       Date:  2012-08-27       Impact factor: 17.425

Review 3.  Hepatogenous Diabetes: A Primer.

Authors:  Preetam Nath; Anil C Anand
Journal:  J Clin Exp Hepatol       Date:  2021-05-01

4.  Liver and diabetes. A vicious circle.

Authors:  Paola Loria; Amedeo Lonardo; Frank Anania
Journal:  Hepatol Res       Date:  2013-01       Impact factor: 4.288

5.  Obesity, metabolic syndrome, and insulin resistance in urban high school students of minority race/ethnicity.

Authors:  Michael Turchiano; Victoria Sweat; Arthur Fierman; Antonio Convit
Journal:  Arch Pediatr Adolesc Med       Date:  2012-11

6.  Disruption of the sugar-sensing receptor T1R2 attenuates metabolic derangements associated with diet-induced obesity.

Authors:  Kathleen R Smith; Tania Hussain; Elnaz Karimian Azari; Jennifer L Steiner; Julio E Ayala; Richard E Pratley; George A Kyriazis
Journal:  Am J Physiol Endocrinol Metab       Date:  2016-02-16       Impact factor: 4.310

7.  Diabetes and liver cancer risk: A stronger effect in Whites than Blacks?

Authors:  Rebecca Baqiyyah N Conway; Staci Sudenga; Donald McClain; William J Blot
Journal:  J Diabetes Complications       Date:  2020-12-01       Impact factor: 2.852

8.  Sterol regulatory element-binding factor 2 (SREBF-2) predicts 7-year NAFLD incidence and severity of liver disease and lipoprotein and glucose dysmetabolism.

Authors:  Giovanni Musso; Maurizio Cassader; Simona Bo; Franco De Michieli; Roberto Gambino
Journal:  Diabetes       Date:  2012-12-28       Impact factor: 9.461

9.  A low level of serum total testosterone is independently associated with nonalcoholic fatty liver disease.

Authors:  Sunmi Kim; Hyuktae Kwon; Jin-Ho Park; Belong Cho; Donghee Kim; Seung-Won Oh; Cheol Min Lee; Ho-Chun Choi
Journal:  BMC Gastroenterol       Date:  2012-06-12       Impact factor: 3.067

10.  Elevated fasting insulin predicts the future incidence of metabolic syndrome: a 5-year follow-up study.

Authors:  Ki-Chul C Sung; Mi-Hae H Seo; Eun-Jung J Rhee; Andrew M Wilson
Journal:  Cardiovasc Diabetol       Date:  2011-11-30       Impact factor: 9.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.